<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01251081</url>
  </required_header>
  <id_info>
    <org_study_id>VHVHF</org_study_id>
    <nct_id>NCT01251081</nct_id>
  </id_info>
  <brief_title>Effect of the Intensity of Continuous Renal Replacement Therapy</brief_title>
  <official_title>Effect of the Intensity of Continuous Renal Replacement Therapy in Patients With Sepsis and Acute Kidney Injury: Single-center Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with sepsis and AKI, increasing the intensity of renal replacement therapy from
      50 mL/kg/h (HVHF) to 85 mL/kg/h (EHVHF)will increase the survival at 28 days and 90 days.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>90 days survival</measure>
    <description>The primary study outcome was death from any cause within 90 days. Results were analyzed by Kaplan-Meier survival curves</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of stay in the ICU and hospital</measure>
    <description>Secondary outcomes were length of stay in the ICU and hospital and renal outcome of survivors at 90 days after randomization.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Optimal Intensity of Renal Replacement Therapy on Sepsis Patients</condition>
  <arm_group>
    <arm_group_label>extra high volume hemofiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>extra high volume hemofiltration (85 mL/kg/h, EHVHF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high volume hemofiltration</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>high volume hemofiltration (50 mL/kg/h, HVHF)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>extra high volume hemofiltration</intervention_name>
    <description>extra high volume hemofiltration (85 mL/kg/h, EHVHF)</description>
    <arm_group_label>extra high volume hemofiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>high volume hemofiltration</intervention_name>
    <description>high volume hemofiltration (50 mL/kg/h, HVHF)</description>
    <arm_group_label>high volume hemofiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        met at least one of the following criteria: oliguria (urine output less than 100 mL in a 6
        h period and unresponsive to fluid resuscitation), serum potassium concentration more than
        6.5 mmol/L, severe acidemia (pH &lt; 7.2), serum creatinine more than 250 µmol/L, or presence
        of severe organ edema (e.g. pulmonary edema).

        Exclusion Criteria:

          -  were presence of a malignant tumor, chronic renal insufficiency (serum creatinine &gt;133
             µmol/L), or receiving any kind of renal replacement therapy before randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jianghua chen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kidney disease center, the first affiliated hospital, medical college of Zhejiang university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kidney disease center, the first affiliated hospital, medical college of Zhejiang university</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2010</study_first_submitted>
  <study_first_submitted_qc>November 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2010</study_first_posted>
  <last_update_submitted>November 30, 2010</last_update_submitted>
  <last_update_submitted_qc>November 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2010</last_update_posted>
  <keyword>high volume hemofiltration</keyword>
  <keyword>sepsis</keyword>
  <keyword>acute kidney injury</keyword>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

